Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.1
    -10.4 (-0.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,531.6
    -399.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,354.0
    -32.4 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,143.9
    -34.4 (-0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.8M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ISORAY INC ISORAY
Updated on 07 Aug 2020 (End of trading day)
Last (USD): 0.658 Change: +0.007 High: 0.658 Remarks: -
Change (%): +1.03 Low: 0.635
Open 0.650 Yesterday's Close 0.6513
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 216,896 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.09370 Trailing EPS (USD) e -0.06114 NAV (USD) b 0.1057
PE a - Trailing PE f - Price / NAV b 6.2252
Dividend (USD) d - Cash In Hand (USD) g 0.0437 Issued & Paid-up Shares c 67,651,000
Dividend Yield (%) d - Price / Cash In Hand g 15.057 Treasury Shares h -
Market Cap (M) 36.201 Enterprise Value (M) 34.858
Piotroski F Score 4 Exchange Code ISR Par Value ( $ ) n.a.
52 Weeks Volatility (%) 71.50 Free Float (%) 98.7
Sector & Industry Health Technology - Pharmaceuticals: Other
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Feb 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 May 2016.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ISORAY INC NYSE American 36.201 - - 6.2252 -
Industry Pharmaceuticals: Other NYSE American 52.899 2.025 12.722 8.6998 -
Local Peer AMPIO PHARMACEUTICALS INC NYSE American 69.597 - - 10.9677 -
Global Peer HORIZON THERAPEUTICS PLC NASDAQ 15,703.348 27.405 30.350 6.6487 -
Global Peer CATALENT INC NYSE 14,351.431 108.723 138.260 6.5601 -
Global Peer FOSUN PHARMA HKEx 96,749.513 25.687 25.687 2.7172 1.139
Global Peer ICON PLC NASDAQ 9,994.792 26.725 29.988 6.3319 -
Global Peer ARGENX SE SPON ADR EACH REP 1 ORD SHS NASDAQ 9,867.759 - - 5.4352 -
Global Peer JAZZ PHARMACEUTICALS PLC NASDAQ 6,992.220 13.360 52.480 2.2255 -
Global Peer PERRIGO COMPANY PLC NYSE 6,885.416 47.128 28.665 1.1650 1.621
Global Peer BAUSCH HEALTH COMPANIES INC NYSE 6,407.624 - - 13.5186 -
Global Peer MYOKARDIA INC NASDAQ 5,480.521 - - 6.0316 -
Global Peer Kalbe Farma Tbk. IDX 74,059,221.500 29.544 28.094 4.5320 1.266
Other Global Peers UNITED THERAPEUTICS CORP (NASDAQ), LIVZON PHARMA (HKEx), GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00 (NASDAQ), AXSOME THERAPEUTICS INC (NASDAQ), AMARIN CORP ADR EACH REP 1 ORD GBP0.50 (NASDAQ), BELLRING BRANDS INC (NYSE), SAGE THERAPEUTICS INC (NASDAQ), PACIRA BIOSCIENCES INC (NASDAQ), LUYE PHARMA (HKEx), PRESTIGE CONSUMER HEALTHCARE INC (NYSE), REVOLUTION MEDICINES INC (NASDAQ), REVANCE THERAPEUTICS INC (NASDAQ), IRONWOOD PHARMACEUTICALS INC (NASDAQ), MADRIGAL PHARMACEUTICALS INC (NASDAQ), CORCEPT THERAPEUTICS INC (NASDAQ), INTERCEPT PHARMACEUTICALS INC (NASDAQ), INNOVIVA INC (NASDAQ), ZOGENIX INC (NASDAQ), FUDANZHANGJIANG (HKEx), SUPERNUS PHARMACEUTICALS INC (NASDAQ), THERAVANCE BIOPHARMA INC (NASDAQ), MEGA (SET), BLACKMORES LTD (ASX), SIHUAN PHARM (HKEx), TONG REN TANG (HKEx), HEC PHARM (HKEx), AMPHASTAR PHARMACEUTICALS INC (NASDAQ), ENDO INTERNATIONAL PLC (NASDAQ), CLINUVEL PHARMACEUTICALS LTD (ASX), Indofarma Tbk. (IDX), ASSEMBLY BIOSCIENCES INC (NASDAQ), EAGLE PHARMACEUTICALS INC (NASDAQ), INTERSECT ENT INC (NASDAQ), Tianjin ZX USD (SGX), COLLEGIUM PHARMACEUTICAL INC (NASDAQ), AERIE PHARMACEUTICALS INC (NASDAQ), HUA HAN HEALTH (HKEx), ANIKA THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED (ASX), BIODELIVERY SCIENCES INTERNATIONAL (NASDAQ), CATALYST PHARMACEUTICALS INC (NASDAQ), ANI PHARMACEUTICALS INC (NASDAQ), ALBIREO PHARMA INC (NASDAQ), SHANDONG XINHUA (HKEx), CONSUN PHARMA (HKEx), MEI PHARMA INC (NASDAQ), AGILE THERAPEUTICS INC (NASDAQ), MARINUS PHARMACEUTICALS INC (NASDAQ), CERECOR INC (NASDAQ), GOLDEN THROAT (HKEx), TONIX PHARMACEUTICALS HLDG CORP (NASDAQ), MALLINCKRODT PLC (NYSE), LIPOCINE INC (NASDAQ), ACELRX PHARMACEUTICALS INC (NASDAQ), QUALIGEN THERAPEUTICS INC (NASDAQ), EVOKE PHARMA INC (NASDAQ), DOD (SET), ADAMAS PHARMACEUTICALS INC (NASDAQ), ZYNERBA PHARMACEUTICALS INC (NASDAQ), VERONA PHARMA SPON ADR EACH REP 8 ORD SHS (NASDAQ), GALMED PHARMACEUTICALS LTD (NASDAQ), JILIN CHANGLONG (HKEx), CTI BIOPHARMA CORP (NASDAQ), ORAMED PHARMACEUTICALS INC (NASDAQ), ACLARIS THERAPEUTICS INC (NASDAQ), YSPSAH (Bursa), OCI INTL (HKEx), ACASTI PHARMA INC (NASDAQ), C HEALTH GP (HKEx), CASSAVA SCIENCES INC (NASDAQ), LONGRUN TEA (HKEx), SCYNEXIS INC (NASDAQ), HAPPINESS BIOTECH GROUP LTD (NASDAQ), ALTHEA GROUP HOLDINGS LTD (ASX), CUMBERLAND PHARMACEUTICALS INC (NASDAQ), NATURAL ALTERNATIVES INTERNATIONAL (NASDAQ), PHARMAUST LIMITED (ASX), TIANDA PHARMA (HKEx), BIOLINE RX LTD SPON ADS EACH REPR 15 ORD SHS (NASDAQ), Pyridam Farma Tbk (IDX), HEPION PHARMACEUTICALS INC (NASDAQ), LANSEN PHARMA (HKEx), EAGLE HEALTH HOLDINGS LTD (ASX), BOTANIX PHARMACEUTICALS LTD (ASX), NEOS THERAPEUTICS INC (NASDAQ), INTEC PHARMA LTD (NASDAQ), ANTISENSE THERAPEUTICS (ASX), PLX PHARMA INC (NASDAQ), IDT AUSTRALIA LIMITED (ASX), VITA LIFE SCIENCES LIMITED (ASX), REGULUS THERAPEUTICS INC (NASDAQ), EYEGATE PHARMACEUTICALS INC (NASDAQ), SONOMA PHARMACEUTICALS INC (NASDAQ), CANNPAL ANIMAL THERAPEUTICS LTD (ASX), CRONOS AUSTRALIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.022
+3.46 %
10 Days --0.034
-4.91 %
20 Days --0.001
-0.15 %
Medium Term Return 3 Months --0.012
-1.79 %
6 Months --0.252
-27.69 %
1 Year -+0.307
+87.46 %
Long Term Return 2 Years -+0.079
+13.64 %
3 Years -+0.118
+21.85 %
5 Years --0.862
-56.71 %
Annualised Return Annualised --
-15.42 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.287 - 1.060 Change From 1 Year Low +0.370 % Change From 1 Year Low (%) +128.87
Change From 1 Year High -0.402 % Change From 1 Year High (%) -37.92
2 Years Range 0.269 - 1.060 Change From 2 Years Low +0.389 % Change From 2 Years Low (%) +144.52
Change From 2 Years High -0.402 % Change From 2 Years High (%) -37.92
5 Years Range 0.269 - 1.650 Change From 5 Years Low +0.389 % Change From 5 Years Low (%) +144.52
Change From 5 Years High -0.992 % Change From 5 Years High (%) -60.12
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

Historical Price Data

Date Open High Low Close Volume VWAP
07 Aug 2020 0.650 0.658 0.635 0.658 216,896 -
06 Aug 2020 0.680 0.705 0.620 0.651 532,746 -
05 Aug 2020 0.654 0.690 0.650 0.681 197,872 -
04 Aug 2020 0.698 0.698 0.655 0.675 160,850 -
03 Aug 2020 0.655 0.664 0.650 0.664 180,585 -
31 Jul 2020 0.650 0.660 0.636 0.636 142,550 -
30 Jul 2020 0.660 0.670 0.630 0.646 196,357 -
29 Jul 2020 0.690 0.700 0.661 0.665 121,461 -
28 Jul 2020 0.691 0.708 0.672 0.683 174,180 -
27 Jul 2020 0.705 0.720 0.680 0.700 222,268 -
24 Jul 2020 0.720 0.732 0.690 0.692 313,263 -
23 Jul 2020 0.687 0.720 0.664 0.702 879,589 -
22 Jul 2020 0.650 0.689 0.650 0.670 226,684 -
21 Jul 2020 0.660 0.668 0.640 0.653 166,935 -
20 Jul 2020 0.670 0.690 0.648 0.660 161,468 -
17 Jul 2020 0.660 0.680 0.650 0.668 221,284 -
16 Jul 2020 0.629 0.682 0.600 0.650 390,461 -
15 Jul 2020 0.640 0.650 0.626 0.628 214,352 -
14 Jul 2020 0.640 0.649 0.620 0.638 289,989 -
13 Jul 2020 0.660 0.680 0.634 0.645 346,511 -
10 Jul 2020 0.700 0.719 0.633 0.658 504,518 -
09 Jul 2020 0.620 0.709 0.602 0.700 923,814 -
Summary
Current 2 Weeks
(27 Jul 2020 to 07 Aug 2020)
0.705 0.720 0.620 0.658 2,145,765 -
Previous 2 Weeks
(13 Jul 2020 to 24 Jul 2020)
0.660 0.720 0.620 0.692 3,210,536 -
4 Weeks from
(12 Jun 2020 to 10 Jul 2020)
0.670 0.720 0.620 0.659 8,166,089 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.